Obstructive Hypertrophic Cardiomyopathy (oHCM) Clinical Trials
2 recruiting trials for Obstructive Hypertrophic Cardiomyopathy (oHCM). Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT07367724
Ademetionine in Obstructive Hypertrophic Cardiomyopathy
This study is a multicenter, double-blind, randomized controlled Phase 2 trial designed to evaluate the safety and efficacy of Ademetionine in patients with obstructive...
Sponsor: China National Center for Cardiovascular DiseasesEnrolling: 443 locations
RECRUITINGNCT07383025
Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan
The purpose of this study is to assess the real-world effectiveness and safety of mavacamten in patients with obstructive hypertrophic cardiomyopathy (HCM) receiving mavacamten in...
Sponsor: Bristol-Myers SquibbEnrolling: 2001 location